Nikolaus Trede

Company: Century Therapeutics

Job title: Senior Vice President & Head of Clinical Development

Seminars:

Optimizing Engineered Stealth Features for Allogeneic Cell Therapies 2:10 pm

Comprehensive allo-evasion engineering addressing both cellular and humoral allo-rejection mechanisms: HLA knock-out to prevent T-cell rejection HLA class I surrogate overexpression and TASR technology to prevent NK cell rejection Sharing preclinical and clinical insights of this approach in NHL and autoimmune diseaseRead more

day: Day 1 - Track A - PM

Evaluating Donor-Derived Versus iPSC-Derived NK Therapies to Understand Advantages & Drawbacks of Each 1:05 pm

Dive into the source of NK cell therapies in this dynamic workshop, where we debate donor-derived versus iPSC-derived NK cells. Uncover the distinct advantages and challenges of each approach, from clinical effectiveness, editing efficiency to scalability. Gain the insights needed to make strategic decisions in sourcing NK cells. Comparing and contrasting different sources of NK cells to understand…Read more

day: Pre-Conference Workshop Day